Site Map
Site Map
Our Technology 
Respiratory Organoid Platform: Supporting Vaccine & Drug Development
Organoid Culture Products: Engineered for Highly Efficient Organoid Culture
Organoid Biobank: Designed for
Research & Therapeutic Development
Preclinical Services: Supporting Pharma & Biotech CompaniesHuman-Relevant Models: Organoids derived from human adult stem cells, replicating the entire human respiratory (nasal, airway and alveolar) epithelium. Tailored for viral infections and chronic lung diseases including asthma, COPD, and fibrosis.Platform Robustness: High Efficiency (>95%) and Long-term Stability (>12 passages).High-Throughput & Personalized Medicine: Ideal for neutralizing antibody evaluation, toxicity profiling, drug discovery, precision diagnostics and personalized treatment development.Regulatory: Aligned with FDA-endorsed New Approach Methodologies (NAMs) for non-animal, human-relevant testing platforms.
Organoid Research Suite: One-Stop Solution for Organoid-Based Research
A serum-free culture system for the efficient and reproducible establishment of human respiratory organoids. It supports consecutive organoid expansion for over 12 passages while preserving genotypic and phenotypic stability.
PulmoOrg™ Respiratory Organoid Differentiation Medium
A high-performance media system designed to induce the differentiation of respiratory organoids. When used in combination with our Respiratory Organoid Expansion Kit or Respiratory Organoid Expansion Medium, this system supports respiratory organoid maturation, phenotypic expression, and functional readiness.
For Enquiry: info@biomorgan.hk
Designed for efficient establishment and serial propagation of human intestinal organoids. Deliver >95% success rate with high reproducibility and supports long-term culture exceeding 12 passages while maintaining genotypic and phenotypic stability.
EnteroOrg™ Intestinal Organoid Differentiation Kit
A high-performance media system designed to induce the differentiation of intestinal organoids. When used in combination with our Intestinal Organoid Expansion Kit or Intestinal Organoid Expansion Medium, this system supports organoid maturation, phenotypic expression, and functional readiness.
For Enquiry: info@biomorgan.hk
Pre-formulated, serum-free media designed for immediate use in cancer organoid expansion workflows. Deliver high consistency, minimize preparation time, and offer customizable options to support diverse cancer types and experimental requirements.
For Enquiry: info@biomorgan.hk
SkinOrg™ kit constructs human skin organoids with a bilayered epidermis-dermis structure, recapitulating key features such as keratinization, melanin synthesis, and barrier function. Suitable for skin pathology modeling, topical toxicity testing of cosmetics and drugs, and wound healing or tissue engineering applications.
For Enquiry: info@biomorgan.hk
Basement Membrane Extracts (BME) are extracellular matrix (ECM) complexes isolated and purified from biological tissues, specifically formulated to mimic the structure and function of native basement membranes
Key Features: High Viability; Supports Respiratory Modeling
Key Features: Patient-derived; Tailored to Cancer Type and Donor Profile for Drug Screening
Key Features: Ideal for Secretion Profiling, Luminal Exposure Studies, Infection and Drug Screening
Key Features: Air-Liquid Interface (ALI); Supports Mucociliary Function, TEER Assays, Viral Infection and Neutralizing Antibody Evaluation
BiomOrgan Limited is a Hong Kong-based life science company founded in 2021 and strategically located at the Hong Kong Science and Technology Parks (HKSTP). It is a spin-off from the Centre for Virology, Vaccinology, and Therapeutics (CVVT) Limited, established in collaboration with a group of organoid scientists at the University of Hong Kong.
We provide an organoid-based preclinical solutions from early discovery to safety assessment supporting drug development, toxicology profiling, and disease modeling using high-quality human organoids.
We bring together the right people: scientists, strategists, and innovators with deep expertise in organoid technology, translational research, and commercialization to deliver impactful, human-relevant preclinical solutions.
With laboratories at Hong Kong Science Park and HKU, we support collaborative organoid research and preclinical development through robust infrastructure, advanced workflows, and translational assay capabilities.
Join us to advance human-relevant science. We welcome collaborators and innovators passionate about organoid technology, translational research, and building impactful solutions for preclinical development.
Company Profile
Products and Services
Core Team
Facilities & Qualifications
Join Us
News Trends
Selected Partners
Organoid-Based Solutions for Human-Relevant Drug Discovery and Safety Profiling.
Join us to drive organoid innovation across Asia’s biotech research and development ecosystem.
Reach out to explore partnerships, request services, or learn how our organoid platform can support your research goals.
Contact Us
+852 5986 3278
Add：6/F, 17W Science Park West Ave., Shatin, Hong Kong
Email：info@biomorgan.hk
